More collaboration is needed to understand chemo brain fog

04/2/2013 | Scientist, The (free registration)

Researchers are studying the effects of cancer drugs on the brain in an effort to understand and prevent cognitive decline, or "chemo brain." Mouse studies have shown exercise and the antidepressant fluoxetine might slow or reverse cognitive decline, but the studies do not reflect real-world chemotherapy regimens, writes Ellen Walker, a professor of pharmaceutical sciences at Temple University who is researching chemo brain. The scientific community needs to develop more informative models and set standards for cognitive testing to identify at-risk patients and develop preventive therapies, Walker writes.

View Full Article in:

Scientist, The (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health